Directors & Boards

The Case for the Executive Chair

The Standard

Drug firms slow to cut China ties

Bloomberg

Companies Hold Back on Cutting China Ties Ahead of Biosecure Act (Subscription required)

BioWorld

Biosecure Act leaves biopharmas less confident in Chinese partners (Subscription required)

BioSpace logo

BIOSECURE Act Erodes Industry Confidence in Chinese Contractors: Report

Hospital and Healthcare

Funding for six digital health tech companies

Politico logo

The SCOTUS case you might have missed

STAT logo

Report shows U.S. biotechs are wary of Chinese partnerships due to looming BIOSECURE Act (Subscription required)

Fierce Pharma

BIOSECURE Act hurts US biopharma industry's confidence in Chinese partners: survey

Cosmetics Business

Cosmetics Business reveals the top 5 beauty consumer trends of 2024 in new report

Consultancy Middle East

L.E.K. Consulting expands in UAE and launches KSA office

Consultancy Australia

Sustainability concerns continue to rise among Australian consumers

World economic forum

Climate change is affecting people’s health – here’s how the private sector can help

Supply Chain Dive

Companies lean into SKU simplification

Bloomberg

Legacy Airlines Are Thriving With Ultracheap Fares, Crushing Budget Carriers (Subscription required)

MoneyWeek

Speed bumps will not slow the car industry (Subscription required)

Healthcare Business International

The UK's missing middle market for dementia care (Subscription required)

Packaging Dive

SKU rationalization is in. What does that mean for packaging partners?

AgNews

The new generation drives biological inputs in Brazil

Medium

The Art of Nutritious Indulgence: Balancing Flavor and Health Through Recipe Modifications

Consultancy UK

Businesses need to do more than present sustainability as luxury product

Roll Call

Auto parts suppliers fear a crash with shift to EVs

Financial Times

Western companies drive Chinese biotech licensing deal blitz (Subscription required)

Financial Times

欧美药企推动中国生物技术公司授权交易热潮(英文)

MedCity News

Navigating Opportunities and Challenges in the GLP-1 Drug Gold Rush